n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine has been researched along with sphingosine in 4 studies
| Studies (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Trials (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Recent Studies (post-2010) (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Studies (sphingosine) | Trials (sphingosine) | Recent Studies (post-2010) (sphingosine) |
|---|---|---|---|---|---|
| 78 | 0 | 12 | 8,325 | 117 | 3,459 |
| Protein | Taxonomy | n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine (IC50) | sphingosine (IC50) |
|---|---|---|---|
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 6.3125 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | 0.098 | |
| Sphingosine kinase 2 | Homo sapiens (human) | 1.56 | |
| Sphingosine kinase 1 | Homo sapiens (human) | 3.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allan, D | 1 |
| Lippincott-Schwartz, J; Loew, L; Terasaki, M; Zaal, K | 1 |
| Chazotte, B | 1 |
| Matsuzaki, W; Murayama, T; Nakamura, H; Okamoto, A; Sasaki, H; Toyomura, K; Yamaguchi, N | 1 |
4 other study(ies) available for n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and sphingosine
| Article | Year |
|---|---|
Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Apoptosis; Boron Compounds; Cell Line; Ceramides; Cholesterol; Cricetinae; Fibroblasts; Kidney; Lipid Metabolism; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Sphingolipids; Sphingomyelins; Sphingosine | 2000 |
Fluorescent staining of subcellular organelles: ER, Golgi complex, and mitochondria.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Carbocyanines; Cells, Cultured; Ceramides; Coloring Agents; Endoplasmic Reticulum; Fluorescent Dyes; Golgi Apparatus; Intracellular Membranes; Mitochondria; Rhodamines; Specimen Handling; Sphingosine; Staining and Labeling; Tissue Fixation | 2001 |
Labeling Golgi with fluorescent ceramides.
Topics: 4-Chloro-7-nitrobenzofurazan; Ceramides; Cytological Techniques; Fluorescent Dyes; Golgi Apparatus; Sphingosine; Staining and Labeling | 2012 |
Regulation of alkaline ceramidase activity by the c-Src-mediated pathway.
Topics: 4-Chloro-7-nitrobenzofurazan; Alkaline Ceramidase; Animals; Calcium; Caproates; Cell Line, Tumor; Ceramides; CHO Cells; Cricetulus; CSK Tyrosine-Protein Kinase; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hydrogen-Ion Concentration; Indoles; Lysophospholipids; Membrane Transport Modulators; RNA, Small Interfering; Signal Transduction; Sphingosine; src-Family Kinases; Staining and Labeling; Sulfonamides; Vanadates | 2014 |